Adults 50 and Older Should Get the Two-Dose Shingrix Shingles Vaccine, CDC Says

The Centers for Disease Control and Prevention (CDC) recommends the shingles vaccine Shingrix, given in two doses, for all adults aged 50 and older, and for adults 19 and older whose immune systems are weakened by disease or treatment. There is no maximum age for vaccination. Shingrix is the only shingles vaccine currently in use in the United States.
According to the CDC, about one in three people in the United States will develop shingles in their lifetime. Shingrix is highly effective: it prevents shingles with 97% efficacy in adults aged 50 to 69 and 91% in those 70 and older, and it prevents postherpetic neuralgia, the most common complication, with 91% efficacy in adults 50 and older and 89% in those 70 and older. Efficacy in immunocompromised adults ranges from 68% to 91%, and protection remains high for at least seven years in adults vaccinated at 70 or older.
The two doses are usually given 2 to 6 months apart. Side effects such as a sore arm, tiredness and headache are common and usually last two to three days. The CDC advises that people who have had shingles before, or who received the discontinued older vaccine Zostavax, should still get Shingrix.
On cost, since 2023, people enrolled in Medicare Part D pay nothing out of pocket for Shingrix. Those interested can ask their doctor or pharmacy about an appointment.
(Source: Centers for Disease Control and Prevention)
Source: Centers for Disease Control and Prevention
Published by GSM · USA (original Chinese edition)
Photo: 图片来源:Wikimedia Commons,带状疱疹疫苗Shingrix包装,Whispyhistory摄,CC BY-SA 4.0 | Image: Wikimedia Commons, Shingrix shingles vaccine packaging, photo by Whispyhistory, CC BY-SA 4.0

